| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |